Home

Studies

PT-141 (bremelanotide) for treatment of hypoactive sexual desire disorder

PT-141 (bremelanotide) for treatment of hypoactive sexual desire disorder

New England Journal of Medicine

2019

Study summary

Bremelanotide evaluated for female sexual desire disorder.

Open full study

Peptides studied

PT-141

Goals studied

Peptides for Libido

Stack studied

Libido Stack

Key findings

Improved sexual desire scores compared with placebo.

Study details

Study type

randomized clinical trial

Journal

New England Journal of Medicine

DOI / PubMed

10.1056/NEJMoa1813163

Year

2019

Explore peptide profiles

Discover compounds, understand their mechanisms, and explore the research behind each peptide.

View all peptides

Peptides

Goals

Comparisons

Studies

About

Contact

Search...

Search...

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.

Explore the science. Follow the connections.

Start with a peptide, a goal, a mechanism, or a study. Discover how every piece of research connects across the platform.

Search peptides, goals, studies,...

Research made connected. Build for curious minds.

© 2026 All rights reserved

This platform is for informational and research purposes only. It does not provide medical advice. Always consult a qualified healthcare provider.